Intrinsic	JJ
defence	NN
capacity	NN
and	CC
therapeutic	JJ
potential	NN
of	IN
natriuretic	JJ
peptides	NNS
in	IN
pulmonary	JJ
hypertension	NN
associated	VBN
with	IN
lung	NN
fibrosis	NN
.	.

BACKGROUND	NN
AND	CC
PURPOSE	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
fibro-proliferative	JJ
disorder	NN
refractory	JJ
to	TO
current	JJ
therapy	NN
commonly	RB
complicated	VBN
by	IN
the	DT
development	NN
of	IN
pulmonary	JJ
hypertension	NN
(	(
PH	NN
)	)
;	:
the	DT
associated	VBN
morbidity	NN
and	CC
mortality	NN
are	VBP
substantial	JJ
.	.

Natriuretic	JJ
peptides	NNS
possess	VBP
vasodilator	NN
and	CC
anti-fibrotic	JJ
actions	NNS
,	,
and	CC
pharmacological	JJ
augmentation	NN
of	IN
their	PRP$
bioactivity	NN
ameliorates	VBZ
renal	JJ
and	CC
myocardial	JJ
fibrosis	NN
.	.

Here	RB
,	,
we	PRP
investigated	VBD
whether	IN
natriuretic	JJ
peptides	NNS
possess	VBP
an	DT
intrinsic	JJ
cytoprotective	JJ
function	NN
preventing	VBG
the	DT
development	NN
of	IN
pulmonary	JJ
fibrosis	NN
and	CC
associated	VBN
PH	NN
,	,
and	CC
whether	IN
therapeutics	NNS
targeting	VBG
natriuretic	JJ
peptide	NN
signalling	NN
demonstrate	VBP
efficacy	NN
in	IN
this	DT
life-threatening	JJ
disorder	NN
.	.

EXPERIMENTAL	JJ
APPROACH	NN
:	:
Pulmonary	JJ
haemodynamics	NNS
,	,
right	JJ
ventricular	JJ
function	NN
and	CC
markers	NNS
of	IN
lung	NN
fibrosis	NN
were	VBD
determined	VBN
in	IN
wild-type	JJ
(	(
WT	JJ
)	)
and	CC
natriuretic	JJ
peptide	NN
receptor	NN
(	(
NPR	NN
)	)
-	:
A	DT
knockout	NN
(	(
KO	NN
)	)
mice	NNS
exposed	VBN
to	TO
bleomycin	NN
(	(
1	CD
mg	NN
kg	NN
(	(
-1	CD
)	)
)	)
.	.

Human	JJ
myofibroblast	NN
differentiation	NN
was	VBD
studied	VBN
in	FW
vitro	FW
.	.

KEY	JJ
RESULTS	NNS
:	:
Exacerbated	VBN
cardiac	JJ
,	,
vascular	JJ
and	CC
fibrotic	JJ
pathology	NN
was	VBD
observed	VBN
in	IN
NPR-A	NN
KO	NN
animals	NNS
,	,
compared	VBN
with	IN
WT	JJ
mice	NNS
,	,
exposed	VBN
to	TO
bleomycin	NN
.	.

Treatment	NN
with	IN
a	DT
drug	NN
combination	NN
that	WDT
raised	VBD
circulating	VBG
natriuretic	JJ
peptide	NN
levels	NNS
(	(
ecadotril	NN
)	)
and	CC
potentiated	VBD
natriuretic	JJ
peptide-dependent	JJ
signalling	NN
(	(
sildenafil	NN
)	)
reduced	VBD
indices	NNS
of	IN
disease	NN
progression	NN
,	,
whether	IN
administered	VBN
prophylactically	RB
or	CC
to	TO
animals	NNS
with	IN
established	JJ
lung	NN
disease	NN
.	.

This	DT
positive	JJ
pharmacodynamic	JJ
effect	NN
was	VBD
diminished	VBN
in	IN
NPR-A	NN
KO	NN
mice	NNS
.	.

Atrial	JJ
natriuretic	JJ
peptide	NN
and	CC
sildenafil	NN
synergistically	RB
reduced	VBD
TGFb-induced	JJ
human	JJ
myofibroblast	NN
differentiation	NN
,	,
a	DT
key	JJ
driver	NN
of	IN
remodelling	NN
in	IN
IPF	NN
patients	NNS
.	.

CONCLUSIONS	NNS
AND	CC
IMPLICATIONS	NNS
:	:
These	DT
data	NNS
highlight	VBP
an	DT
endogenous	JJ
host-defence	NN
capacity	NN
of	IN
natriuretic	JJ
peptides	NNS
in	IN
lung	NN
fibrosis	NN
and	CC
PH.	NN
A	DT
combination	NN
of	IN
ecadotril	NN
and	CC
sildenafil	NN
reversed	VBD
the	DT
pulmonary	JJ
haemodynamic	JJ
aberrations	NNS
and	CC
remodelling	VBG
that	IN
characterize	VBP
the	DT
disease	NN
,	,
advocating	VBG
therapeutic	JJ
manipulation	NN
of	IN
natriuretic	JJ
peptide	NN
bioactivity	NN
in	IN
patients	NNS
with	IN
IPF	NN
.	.

